Drug Shortage Report for SANDOZ ANASTROZOLE
Report ID | 137306 |
Drug Identification Number | 02338467 |
Brand name | SANDOZ ANASTROZOLE |
Common or Proper name | SANDOZ ANASTROZOLE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ANASTROZOLE |
Strength(s) | 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30FCT UD CA |
ATC code | L02BG |
ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-04-09 |
Estimated end date | 2021-04-23 |
Actual end date | 2021-04-16 |
Shortage status | Resolved |
Updated date | 2021-04-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-04-20 | French | Compare |
v3 | 2021-04-20 | English | Compare |
v2 | 2021-04-12 | French | Compare |
v1 | 2021-04-12 | English | Compare |
Showing 1 to 4 of 4